Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.23B 50.31B | Sales 2025 * | 48.12B 51.26B | Capitalization | 25.86B 27.55B |
---|---|---|---|---|---|
Net income 2024 * | 2.36B 2.51B | Net income 2025 * | 3.21B 3.42B | EV / Sales 2024 * | 1.24 x |
Net Debt 2024 * | 32.81B 34.95B | Net Debt 2025 * | 29.7B 31.64B | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
11.4
x | P/E ratio 2025 * |
7.99
x | Employees | - |
Yield 2024 * |
1.3% | Yield 2025 * |
1.43% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |